Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial

With GLP-1-related drugs having won the race to weight loss approval, attention at many obesity-focused biopharmas has turned to the trickier task of finding a way to lose fat while retaining muscle.

Veru is one biotech that thinks it’s found an answer.